News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
413,142 Results
Type
Article (33178)
Company Profile (64)
Press Release (379897)
Multimedia
Podcasts (75)
Webinars (7)
Section
Business (113250)
Career Advice (1334)
Deals (24174)
Drug Delivery (108)
Drug Development (60032)
Employer Resources (105)
FDA (10227)
Job Trends (9134)
News (212695)
Policy (25741)
Tag
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (1848)
Accelerated approval (29)
Adcomms (26)
Allergies (108)
Alliances (42398)
ALS (119)
Alzheimer's disease (1342)
Antibody-drug conjugate (ADC) (247)
Approvals (10362)
Artificial intelligence (338)
Autoimmune disease (99)
Automation (21)
Bankruptcy (238)
Best Places to Work (7693)
BIOSECURE Act (16)
Biosimilars (153)
Biotechnology (42)
Bladder cancer (113)
Brain cancer (57)
Breast cancer (433)
Cancer (3535)
Cardiovascular disease (283)
Career advice (1139)
Career pathing (23)
CAR-T (191)
CDC (53)
Cell therapy (521)
Cervical cancer (26)
Clinical research (50865)
Collaboration (1407)
Company closure (3)
Compensation (970)
Complete response letters (54)
COVID-19 (2595)
CRISPR (62)
C-suite (398)
Cystic fibrosis (87)
Data (4397)
Decentralized trials (1)
Denatured (12)
Depression (102)
Diabetes (387)
Diagnostics (3733)
Digital health (23)
Diversity (8)
Diversity, equity & inclusion (34)
Drug discovery (177)
Drug pricing (176)
Drug shortages (31)
Duchenne muscular dystrophy (191)
Earnings (42764)
Editorial (53)
Employer branding (13)
Employer resources (98)
Events (48341)
Executive appointments (435)
FDA (12462)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (8)
Frontotemporal dementia (17)
Funding (929)
Gene editing (138)
Generative AI (32)
Gene therapy (460)
GLP-1 (937)
Government (4366)
Grass and pollen (6)
Guidances (303)
Healthcare (11433)
HIV (49)
Huntington's disease (39)
IgA nephropathy (63)
Immunology and inflammation (182)
Immuno-oncology (44)
Indications (73)
Infectious disease (2848)
Inflammatory bowel disease (116)
Inflation Reduction Act (11)
Influenza (109)
Intellectual property (158)
Interviews (233)
IPO (10546)
IRA (46)
Job creations (1756)
Job search strategy (959)
JPM (44)
Kidney cancer (10)
Labor market (48)
Layoffs (338)
Leadership (20)
Legal (7099)
Liver cancer (68)
Longevity (14)
Lung cancer (493)
Lymphoma (286)
Machine learning (32)
Management (33)
Manufacturing (561)
MASH (136)
Medical device (6066)
Medtech (6090)
Mergers & acquisitions (14480)
Metabolic disorders (1076)
Multiple sclerosis (109)
NASH (20)
Neurodegenerative disease (236)
Neuropsychiatric disorders (70)
Neuroscience (2238)
Neurotech (1)
NextGen: Class of 2026 (3663)
Non-profit (2791)
Now hiring (9)
Obesity (554)
Opinion (239)
Ovarian cancer (108)
Pain (118)
Pancreatic cancer (179)
Parkinson's disease (214)
Partnered (24)
Patents (312)
Patient recruitment (291)
Peanut (43)
People (25664)
Pharmaceutical (20)
Pharmacy benefit managers (20)
Phase 1 (15366)
Phase 2 (22092)
Phase 3 (17928)
Pipeline (3838)
Policy (271)
Postmarket research (1846)
Preclinical (6387)
Press Release (28)
Prostate cancer (174)
Psychedelics (42)
Radiopharmaceuticals (231)
Rare diseases (640)
Real estate (2608)
Recruiting (47)
Regulatory (17893)
Reports (24)
Research institute (1630)
Resumes & cover letters (196)
Rett syndrome (26)
RNA editing (9)
RSV (80)
Schizophrenia (120)
Series A (128)
Series B (102)
Service/supplier (3)
Sickle cell disease (61)
Special edition (11)
Spinal muscular atrophy (147)
Sponsored (27)
Startups (1913)
State (1)
Stomach cancer (13)
Supply chain (79)
Tariffs (71)
The Weekly (62)
Vaccines (1015)
Venture capital (61)
Weight loss (384)
Women's health (53)
Worklife (11)
Date
Today (2)
Last 7 days (369)
Last 30 days (1403)
Last 365 days (19637)
2026 (1764)
2025 (19914)
2024 (22352)
2023 (25257)
2022 (33380)
2021 (35888)
2020 (34072)
2019 (27908)
2018 (21234)
2017 (20187)
2016 (18692)
2015 (21494)
2014 (15948)
2013 (12876)
2012 (13623)
2011 (14401)
2010 (13078)
Location
Africa (583)
Alabama (50)
Alaska (3)
Arizona (124)
Arkansas (5)
Asia (26962)
Australia (4837)
California (6790)
Canada (2025)
China (782)
Colorado (272)
Connecticut (304)
Delaware (239)
Europe (64717)
Florida (1027)
Georgia (217)
Hawaii (4)
Idaho (30)
Illinois (485)
India (47)
Indiana (330)
Iowa (17)
Japan (338)
Kansas (76)
Kentucky (24)
Louisiana (17)
Maine (32)
Maryland (971)
Massachusetts (4810)
Michigan (163)
Minnesota (240)
Mississippi (1)
Missouri (77)
Montana (21)
Nebraska (11)
Nevada (73)
New Hampshire (27)
New Jersey (2040)
New Mexico (15)
New York (1935)
North Carolina (810)
North Dakota (5)
Northern California (3390)
Ohio (189)
Oklahoma (9)
Oregon (14)
Pennsylvania (1364)
Puerto Rico (12)
Rhode Island (17)
South America (806)
South Carolina (32)
South Dakota (1)
Southern California (2630)
Tennessee (85)
Texas (876)
United States (23978)
Utah (158)
Vermont (1)
Virginia (170)
Washington D.C. (43)
Washington State (527)
West Virginia (2)
Wisconsin (60)
Wyoming (2)
413,142 Results for "bioversys ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioVersys Announces BV100 Phase 3 Initiation and Provides a Business Update
December 11, 2025
·
8 min read
Press Releases
BioVersys Announces First Subjects Dosed in Phase 1 Clinical Trial of Bv100 in China
November 6, 2025
·
6 min read
Press Releases
BioVersys BV100 Phase 2b to be Conducted Via Wellcome Funded Trial Network
November 10, 2025
·
11 min read
Press Releases
Bioversys Reports Corporate Highlights and Key Financials For the First Half 2025
September 10, 2025
·
10 min read
Press Releases
BioVersys Receives EMA Orphan Designation for the Combination of Alpibectir and Ethionamide for the Treatment of Tuberculosis
August 27, 2025
·
7 min read
Press Releases
BioVersys and Shionogi Enter Into Global Research Collaboration For Broad-Spectrum Non-Tuberculous Mycobacteria (NTM) Clinical Candidate
July 2, 2025
·
8 min read
Business
BioVersys Announces Expansion of Strategic Collaboration With GSK and Extension of Its Series C Round by CHF 12.3 Million
BioVersys AG announced the expansion of its strategic collaboration with the global biopharma company GSK plc to accelerate the clinical development of alpibectir for the treatment of tuberculosis.
May 7, 2024
·
4 min read
Press Releases
BioVersys Reports Corporate Highlights and Key Financials for the Full Year 2024
March 26, 2025
·
10 min read
BioVersys Awarded Non-Dilutive Funding From CF AMR Syndicate Collaborative Discovery Programme
BioVersys AG announced that it has received a non-dilutive award from the CF AMR Syndicate of up to £ 500,000, via a LifeArc funded Collaborative Discovery Programme award, to support the development of novel small molecules targeting difficult to treat non-tubercular mycobacteria lung disease in people with cystic fibrosis.
June 4, 2024
·
10 min read
Press Releases
BioVersys Announces Important BV100 Patent Granted by Chinese Patent Office
March 31, 2025
·
5 min read
1 of 41,315
Next
